s6y

3 G1 Therapeutics, Inc.: Initial statement of beneficial ownership of securities

Filed
Period
Accession number
0001562180-21-004391

Documents

  1. PRIMARY DOCUMENT 3
  2. POA EX-24

On sec.gov